1-4 of 4 results for subject:Misuse
Librarians' tools
- Search time
- 0.173 seconds
- Solr query time
- 0.004 seconds
- Search query
- subject:Misuse
- We searched for
- subject_t:Misuse OR subject_t:"Substance misuse" OR subject_ses:92056
Type
House
Session
Month
Department
Member
More
Blair, Tony (4)
Primary member
Answering member
Legislative stage
Legislation
Subject
Publisher
To ask the Prime Minister, if he will appoint a tsar to reduce the deaths and addictions caused by the mis-use of medicinal and other legal drugs. - (Holding answer 14 July 1998).
To ask the Prime Minister, if he will appoint a tsar to reduce the deaths and addictions caused by the mis-use of medicinal and other legal drugs. - (Holding answer 14 July 1998).
Asked by
Paul Flynn
(Labour)
Answered by
Tony Blair
(Labour)
Answering body
Prime Minister
Type
Written questions
Status
Answered
Tabled on
9 July 1998
For answer on
16 July 1998
Answered on
16 July 1998
Mr. Flynn: To ask the Prime Minister if he will appoint a tsar to reduce the deaths and addictions caused by the mis-use of
medicinal and other legal drugs. [50485]
The Prime Minister: [holding answer 14 July 1998]:
Misuse should occur only when prescribers or patients use medicines outside the authorised conditions. Doctors and other healthcare
professionals are individually responsible for the products they prescribe and must be able to justify, if necessary, their
prescribing decisions. In particular, prescribing over large quantities or for excessive periods could be taken up as a terms of
service issue or by the General Medical Council as professional disciplinary matter.
Medicines are authorised for the United Kingdom market only after thorough and expert evaluation by the Medicines Control Agency,
advised by the Committee on Safety of Medicines. The MCA continues to monitor the safety of medicines after they have been placed on
the market and exposed to a greater population than in pre-authorisation tests. Medicines are authorised for use in very specific
circumstances and any contraindications and warnings are shown clearly both to prescribers in the summary of product characteristics
and to patients in information leaflets. We are satisfied that regulatory control, together with information and guidance to
healthcare and patients, provides the necessary safeguards.
Subjects
Drugs; Prescription drugs; Misuse
Date
16 July 1998
Reference
50485; 316 c253W
House
House of Commons
To ask the Prime Minister, If he will list his official engagements for Wednesday 29th April. (Question not printed). -
To ask the Prime Minister, If he will list his official engagements for Wednesday 29th April. (Question not printed). -
Asked by
Stephen Timms
(Labour)
Answered by
Tony Blair
(Labour)
Answering body
Prime Minister
Prime Minister's questions - Lead
Status
Answered
Tabled on
8 April 1998
For answer on
29 April 1998
Answered on
29 April 1998
Subjects
Curriculum; Disadvantaged; Health; Drugs; Medical treatments; Misuse
Date
29 April 1998
Reference
311 c326-7; 39094
Chamber / Committee
House of Commons chamber
House
House of Commons
Answered by
Tony Blair
(Labour)
Answering body
Prime Minister
Type
Oral answers to questions
Subjects
Curriculum; Disadvantaged; Health; Drugs; Medical treatments; Misuse
Date
29 April 1998
Reference
311 c326-7
Chamber / Committee
House of Commons chamber
House
House of Commons
Answered by
Tony Blair
(Labour)
Asked by
Stephen Timms
(Labour)
Answering body
Prime Minister
Type
Oral answers to questions
To ask the Prime Minister, If he will list his official engagements for Wednesday 29th April. (Question not printed). -
Subjects
Curriculum; Disadvantaged; Health; Drugs; Medical treatments; Misuse
Date
29 April 1998
Reference
311 c326-7
Chamber / Committee
House of Commons chamber
House
House of Commons